Shares of Johnson Matthey PLC (LON:JMAT - Get Free Report) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1,384.55 ($18.76) and traded as high as GBX 1,736 ($23.53). Johnson Matthey shares last traded at GBX 1,717 ($23.27), with a volume of 857,300 shares trading hands.
Johnson Matthey Stock Performance
The stock's 50-day moving average price is GBX 1,360.71 and its 200 day moving average price is GBX 1,388.29. The company has a quick ratio of 0.76, a current ratio of 1.45 and a debt-to-equity ratio of 62.73. The company has a market cap of £2.89 billion, a P/E ratio of 29.41, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95.
Johnson Matthey (LON:JMAT - Get Free Report) last announced its earnings results on Thursday, May 22nd. The company reported GBX 149.20 ($2.02) EPS for the quarter. Johnson Matthey had a net margin of 0.84% and a return on equity of 4.49%. As a group, research analysts expect that Johnson Matthey PLC will post 173.4112903 EPS for the current fiscal year.
Johnson Matthey Increases Dividend
The firm also recently declared a dividend, which was paid on Wednesday, April 16th. Stockholders of record on Thursday, April 10th were given a GBX 32 ($0.43) dividend. This is an increase from Johnson Matthey's previous dividend of $22.00. This represents a dividend yield of 1.88%. The ex-dividend date of this dividend was Thursday, April 10th. Johnson Matthey's dividend payout ratio (DPR) is currently 130.84%.
Insider Transactions at Johnson Matthey
In other Johnson Matthey news, insider Liam Condon acquired 30 shares of Johnson Matthey stock in a transaction dated Wednesday, April 16th. The stock was bought at an average cost of GBX 1,200 ($16.26) per share, with a total value of £360 ($487.87). Over the last ninety days, insiders have acquired 75 shares of company stock worth $99,927. Company insiders own 0.61% of the company's stock.
Johnson Matthey Company Profile
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
Further Reading
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
